<?xml version="1.0" encoding="UTF-8"?>
<p>In a single-center, retrospective, observational study of 287 patients, 55 patients presented with AKI as defined by the Kidney Disease Improving Global Outcomes (KDIGO). These patients were significantly older, more likely male, and with other comorbidities, including chronic renal insufficiency, hypertension, and cerebrovascular disease, and tended to have more severe pneumonia (not peer-reviewed) (
 <xref rid="B41" ref-type="bibr">41</xref>). Of these patients, 14.3% presented with AKI at stage 1, while 4.9% of patients presented with stage 2 or 3 (
 <xref rid="B41" ref-type="bibr">41</xref>). A comparison of outcomes according to AKI status and stage found that comparing non-AKI patients to those who developed AKI, the last had higher mortality rates, especially when AKI was severe (mortality: 3.0, 7.3, and 64.3% for non-AKI, AKI stage 1, and AKI stages 2/3, respectively) (
 <xref rid="B41" ref-type="bibr">41</xref>).
</p>
